BASAGLAR KwikPen
Insulin glargine · Eli Lilly and Company
PRESCRIPTION ONLY (USA)BASAGLAR KwikPen ingredients
| Active ingredient | Strength |
|---|---|
| Insulin Glargine | 100 [iU]/mL |
What BASAGLAR KwikPen is used for
BASAGLAR KwikPen is a specialist medicine (insulin analog). Its approved uses are listed on the official FDA label below.
Key facts
- Brand
- BASAGLAR KwikPen
- Generic name
- Insulin glargine
- Made by
- Eli Lilly and Company
- Forms
- Injection, Solution
- Given
- Subcutaneous
- Drug class
- Insulin Analog
- FDA approval
- Biologic licence (BLA) BLA205692
- On the US market since
- 2015
Official information
- BASAGLAR KwikPen prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Insulin glargine)
In India
- Insulin glargine: 16 brands in India
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is BASAGLAR KwikPen?
BASAGLAR KwikPen (Insulin glargine) is a specialist medicine made by Eli Lilly and Company, approved by the US FDA.
What are the ingredients of BASAGLAR KwikPen?
BASAGLAR KwikPen contains Insulin Glargine (100 [iU]/mL).
From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA